According to a new market research study of “South and Central America Neurovascular Devices Market Forecast to 2027 - COVID-19 Impact and Analysis by Product, Application, and End User, The South and Central America neurovascular devices market is expected to reach US$ 224.08 Mn in 2027 from US$ 181.40 Mn in 2019. The market is estimated to grow with a CAGR of 2.8% from 2019-2027. The report highlights trends prevailing in the South and Central America Neurovascular Devices Market instruments market and the factors driving market along with those that act as hindrances.
The South and Central America neurovascular devices market, based on the product was segmented into neurothrombectomy devices, aneurysm coiling & embolization devices, cerebral balloon angioplasty & stenting systems and support devices. The aneurysm coiling & embolization devices held the largest share of the market in 2019, and is expected to register the highest CAGR in the market during the forecast period.
Neurovascular devices are used for the treatment of neurovascular diseases that possibly affects the network of blood vessels that surround the brain. This leads to incurable conditions such as strokes and aneurysms. Neurovascular devices are used to prevent stroke, aneurysm embolization, carotid stenosis and other symptoms. Neurovascular devices are also used for performing surgical procedures to treat aneurysms and other cranial blood flow problems. The prevalence of cerebral aneurysms has increased tremendously across the globe. According to data published on 2019 Dec 20, by Surgical Neurology International, it is estimated that half a million people every year suffer from a brain aneurysm in Brazil. Thus, it is estimated that the rising prevalence of cerebral aneurysms is likely to fuel the growth of the market during the forecast period.
Key factors that are driving growth of the South and Central America Neurovascular Devices market are Increasing Incidences of neurovascular diseases, rising demand for minimally invasive procedures, and significantly growing aging population. However, the market is expected to grow at slower pace owing to the factors such as high cost of embolization coils and lack of expert professionals operating neurovascular disorders.
Penumbra, Inc.; Stryker Corporation; and Medtronic plc are among the leading companies operating in the South and Central America Neurovascular Devices market.
The report segments in South and Central America Neurovascular Devices Market as follows:
By Product
By Application
By End User
By Country
Reasons to Buy
The South and Central America neurovascular devices market, based on the product was segmented into neurothrombectomy devices, aneurysm coiling & embolization devices, cerebral balloon angioplasty & stenting systems and support devices. The aneurysm coiling & embolization devices held the largest share of the market in 2019, and is expected to register the highest CAGR in the market during the forecast period.
Neurovascular devices are used for the treatment of neurovascular diseases that possibly affects the network of blood vessels that surround the brain. This leads to incurable conditions such as strokes and aneurysms. Neurovascular devices are used to prevent stroke, aneurysm embolization, carotid stenosis and other symptoms. Neurovascular devices are also used for performing surgical procedures to treat aneurysms and other cranial blood flow problems. The prevalence of cerebral aneurysms has increased tremendously across the globe. According to data published on 2019 Dec 20, by Surgical Neurology International, it is estimated that half a million people every year suffer from a brain aneurysm in Brazil. Thus, it is estimated that the rising prevalence of cerebral aneurysms is likely to fuel the growth of the market during the forecast period.
Key factors that are driving growth of the South and Central America Neurovascular Devices market are Increasing Incidences of neurovascular diseases, rising demand for minimally invasive procedures, and significantly growing aging population. However, the market is expected to grow at slower pace owing to the factors such as high cost of embolization coils and lack of expert professionals operating neurovascular disorders.
Penumbra, Inc.; Stryker Corporation; and Medtronic plc are among the leading companies operating in the South and Central America Neurovascular Devices market.
The report segments in South and Central America Neurovascular Devices Market as follows:
By Product
- Neurothrombectomy Devices
- Clot Retrieval Devices
- Suction & Aspiration Devices
- Snares
- Aneurysm Coiling & Embolization Devices
- Embolic Coils
- Bare Detachable Coils
- Coated Detachable Coils
- Flow Diversion Devices
- Liquid Embolic Agents
- Cerebral Balloon Angioplasty & Stenting Systems
- Carotid Artery Stents
- Embolic Protection Systems
- Balloon Occlusion Devices
- Distal Fillers
- Support Devices
- Microcatheters
- Microguidewires
By Application
- Cerebral Aneurysms
- Arteriovenous Malformation & Fistulas
- Other Applications
By End User
- Hospitals
- Ambulatory Surgical Centers
- Specialized Clinics
By Country
- Brazil
- Argentina
- Rest of South and Central America
Reasons to Buy
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the South and Central America neurovascular devices market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the South and Central America neurovascular devices market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
Table of Contents
1. Introduction
3. Research Methodology
4. South and Central America Neurovascular Devices- Market Landscape
5. South and Central America Neurovascular Devices Market - Key Industry Dynamics
6. Neurovascular Devices Market - South and Central America Analysis
7. Neurovascular Devices Market Analysis and Forecasts to 2027 Product
8. Neurovascular Devices Market Analysis and Forecasts to 2027 Application
9. Neurovascular Devices Market Analysis and Forecasts to 2027 - End User
10. Neurovascular Devices Market Revenue and Forecasts to 2027 Regional Analysis
11. Impact of COVID-19 Pandemic on South and Central America Neurovascular Devices Market
12. Neurovascular Devices Market-Key Company Profiles
13. Appendix
List of Tables
List of Figures
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Medtronic plc
- Johnson and Johnson, Inc (DePuy Synthes)
- Penumbra, Inc
- Terumo Corporation
- Acandis GmbH & Co. KG